David Nittner
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- Epigenetics and DNA Methylation 3
- Cancer-related gene regulation 2
-
- Cancer-related molecular mechanisms research 3
- MicroRNA in disease regulation 2
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Adrian Liston (2 shared papers)Kathleen Van den Eynde (2 shared papers)Diether Lambrechts (3 shared papers)Peter Carmeliet (1 shared paper)Stein Aerts (1 shared paper)Paul De Leyn (1 shared paper)Bram Boeckx (1 shared paper)Els Wauters (1 shared paper)
- Journals
- Cell Death and Differentiation (2 papers)Nature Communications (1 paper)Journal of Hematology & Oncology (1 paper)Translational Oncology (1 paper)Blood (1 paper)
- Partner nations
- BelgiumUnited StatesNetherlands
In The Last Decade
David Nittner
18 papers receiving 1.9k citations
David Nittner's Hit Papers
Peers
Comparison fields: 5 of 84
- Cancer Research 655
- Oncology 663
- Immunology 449
- Molecular Biology 1.1k
- Pulmonary and Respiratory Medicine 206
Countries citing papers authored by David Nittner
This map shows the geographic impact of David Nittner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Nittner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Nittner more than expected).
Fields of papers citing papers by David Nittner
This network shows the impact of papers produced by David Nittner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Nittner. The network helps show where David Nittner may publish in the future.
Co-authors
The 25 scholars most cited alongside David Nittner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phenotype molding of stromal cells in the lung tumor microenvironment Hit paper breakdown → | 2018 | 1077 |
| 2 | 2009 | 127 | |
| 3 | 2010 | 113 | |
| 4 | 2018 | 108 | |
| 5 | 2013 | 92 | |
| 6 | 2019 | 79 | |
| 7 | 2017 | 74 | |
| 8 | 2012 | 64 | |
| 9 | 2020 | 45 | |
| 10 | 2018 | 22 | |
| 11 | Gemcitabine induces Epithelial-to-Mesenchymal Transition in patient-derived pancreatic ductal adenocarcinoma xenografts. | 2019 | 19 |
| 12 | 2023 | 15 | |
| 13 | 2020 | 15 | |
| 14 | 2022 | 13 | |
| 15 | 2021 | 13 | |
| 16 | 2019 | 12 | |
| 17 | 2022 | 9 | |
| 18 | 2022 | 6 | |
| 19 | 2017 | 0 |
About David Nittner
David Nittner is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Pathology and Forensic Medicine, having authored 19 papers that have together received 1.9k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (3 papers), Cancer-related molecular mechanisms research (3 papers), melanin and skin pigmentation (2 papers), Cancer-related Molecular Pathways (2 papers), Cancer Cells and Metastasis (2 papers), Cancer-related gene regulation (2 papers), MicroRNA in disease regulation (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (655 citations), Oncology (663 citations), Immunology (449 citations), Molecular Biology (1.1k citations) and Pulmonary and Respiratory Medicine (206 citations). David Nittner has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Adrian Liston, Kathleen Van den Eynde, Diether Lambrechts, Peter Carmeliet, Stein Aerts, Paul De Leyn, Bram Boeckx, Els Wauters, Sara Aibar and Bernard Thienpont. Their work appears in journals such as Cell Death and Differentiation, Nature Communications, Journal of Hematology & Oncology, Translational Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.